Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation

Canadian Journal of Veterinary Research

Volumn 71, Issue 3, 2007, Pages 165-174

  Wang, Yu Shan ^a,b   Chi, Kwan Hwa ^b   Liao, Kuang Wen ^c   Liu, Cheng Chi ^a   Cheng, Chiao Lei ^a   Lin, Yi Chun ^a   Cheng, Chiung Hsiang ^a   Chu, Rea Min ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^d NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; FLT3 LIGAND; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A2 ANTIGEN; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BLOOD AUTOTRANSFUSION; CELL ADHESION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOG; FLOW CYTOMETRY; HUMAN; IMMUNOSTIMULATION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MIXED LYMPHOCYTE REACTION; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, CD14; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DOGS; FLOW CYTOMETRY; FMS-LIKE TYROSINE KINASE 3; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA-DR ANTIGENS; IMMUNOGLOBULINS; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; LYMPHOCYTE CULTURE TEST, MIXED; MEMBRANE GLYCOPROTEINS; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

BOVINAE; CANIS FAMILIARIS;

EID: 34447261774     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997;90: 3245-3287.
2. Clark GJ, Angel N, Kato M, et al. The role of dendritic cells in the innate immune system. Microbes Infect 2000;2:257-272.
3. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
4. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
5. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-261.
6. Siena S, Di Nicola M, Bregni M, et al. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. Exp Hematol 1995;23: 1463-1471.
7. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
8. Sallusto F, Lanzavecchia. A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.
9. Thurner B, Haendle I, Roder C, et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999;190:1669-1678.
10. Dhodapkar MV, Krasovsky J, Steinman RM, Bhardwaj N. Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes. J Clin Invest 2000;105: R9-R14.
11. Dhodapkar MV, Steinman RM, Sapp M, et al. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest 1999;104: 173-180.
12. Hagglund HG, McSweeney PA, Mathioudakis G, et al. Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells. Transplantation 2000;70:1437-1442.
13. Weber M, Lange C, Gunther W, Franz M, Kremmer E, Kolb HJ. Minor histocompatibility antigens on canine hemopoietic progenitor cells. J Immunol 2003;170:5861-5868.
14. Yoshida H, Momoi Y, Taga N, et al. Generation of canine dendritic cells from peripheral blood mononuclear cells. J Vet Med Sci 2003;65:663-669.
15. Catchpole B, Stell AJ, Dobson JM. Generation of blood-derived dendritic cells in dogs with oral malignant melanoma. J Comp Pathol 2002;126:238-241.
16. Ibisch C, Pradal G, Bach JM, Lieubeau B. Functional canine dendritic cells can be generated in vitro from peripheral blood mononuclear cells and contain a cytoplasmic ultrastructural marker. J Immunol Methods 2005;298:175-182.
17. Bonnefont-Rebeix C, de Carvalho CM, Bernaud J, Chabanne L, Marchal T, Rigal D. CD86 molecule is a specific marker for canine monocyte-derived dendritic cells. Vet Immunol Immunopathol 2006;109:167-176.
18. Liao KW, Hung SW, Hsiao YW, Bennett M, Chu RM. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells. Vet Immunol Immunopathol 2003;92:149-162.
19. Peretz Y, Zhou ZF, Halwani F, Prud'homme GJ. In vivo generation of dendritic cells by intramuscular codelivery of FLT3 ligand and GM-CSF plasmids. Mol Ther 2002;6:407-414.
20. Sombroek CC, Stam AG, Masterson AJ, et al. Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol 2002;168:4333-4343.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
22. Fujiwara S, Yasunaga S, Iwabuchi S, Masuda K, Ohno K, Tsujimoto H. Cytokine profiles of peripheral blood mononuclear cells from dogs experimentally sensitized to Japanese cedar pollen. Vet Immunol Immunopathol 2003;93:9-20.
23. Kiertscher SM, Luo J, Dubinett SM, Roth MD. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol 2000;164:1269-1276.
24. Shen W, Ladisch S. Ganglioside GD1a impedes lipopolysaccharide-induced maturation of human dendritic cells. Cell Immunol 2002;220:125-133.
25. Chi CH, Wang YS, Lai YS, Chi KH. Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model. Anticancer Res 2003;23:315-321.
26. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood. J Immunol Methods 1996;196:121-135.
27. Chakravarty PK, Alfieri A, Thomas EK, et al. Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Res 1999;59:6028-6032.
28. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-1433.
29. Freudenthal PS, Steinman RM. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci U S A 1990;87:7698-7702.
30. Lauener RP, Goyert SM, Geha RS, Vercelli D. Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol. 1990;20:2375-2381.
31. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-89.
32. Zhou L-J, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83 + dendritic cells. Proc Natl Acad Sci U S A 1996;93:2588-2592.
33. O'Sullivan B, Thomas R. Recent advances on the role of CD40 and dendritic cells in immunity and tolerance. Curr Opin Hematol 2003;10:272-278.
34. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693-1702.
35. Romani N, Reider D, Heuer M, et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996;196:137-151.
36. Yao, V, Platell C, Hall JC. Dendritic cells. Aust N Z J Surg 2002; 72:501-506.
37. Galkowska, H, Waldemar LO, Wojewodzka U. Reactivity of antibodies directed against human antigens with surface markers on canine leukocytes. Vet Immunol Immunopathol 1996;53: 329-334.
38. Anderson HA, Hiltbold EM, Roche PA. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 2000;1:156-162.
39. Holmes MA, Lunn DP. Variation of MHC II expression on canine lymphocytes with age. Tissue Antigens 1994;43:179-183.
40. Cobbold S, Metcalfe S. Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens 1994;43:137-154.